iTAB-CV Study for Hypertension and Biopolar Disorder

I'm Interested!

Using mHealth to improve adherence and reduce blood pressure in individuals with hypertension and bipolar disorder

Sex: Any
Age: Adult (18 - 64), Older Adult (65+)
Accepting Healthy People: No
Type: Others
Trial Phase: NA
Conditions Being Studied: Hypertension, Bipolar Disorder, Depression

Study Purpose

The purpose of this research is to evaluate a brief, practical adherence intervention (iTAB-CV) delivered via interactive text messaging+ Self-Monitoring (SM) compared to SM alone.

Who Can Participate

Participants between 21 years of age and older who are diagnosed with Bipolar Disorder or Major Depressive and hypertension and are taking medication for high blood pressure may be eligible for this study.

Principal Investigator
Jennifer Levin PhD

Department/Division
Psychiatry (General)

Locations

UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106

Get Directions

UH IRB: STUDY20200330
StudyID: STUDY20200330
ClinicalTrials.gov: NCT04675593

I'm Interested!

Fill out our online form

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-800-641-2422